Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer | Semantic Scholar
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
The current treatment paradigm for patients with metastatic colorectal... | Download Scientific Diagram
Beyond KRAS status and response to anti-EGFR therapy in metastatic colorectal cancer | Pharmacogenomics
Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients | Nature Communications
The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC) - ScienceDirect
Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020 | Published in healthbook TIMES Oncology Hematology
Colorectal Cancer – Treatments | Gastrointestinal Cancer
Cancers | Free Full-Text | Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer
The Trouble With KRAS - Cancer Commons
KRAS-Targeted Therapy Doubles as Component of Immunotherapy - NCI
Frontiers | Retrospective Comparative Analysis of KRAS G12C vs. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + Bevacizumab
The current understanding on the impact of KRAS on colorectal cancer - ScienceDirect
TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers - ScienceDirect
Frontiers | Molecular Network of Colorectal Cancer and Current Therapeutic Options
RAS mutations: impact on treatment outcome | Colorectal Cancer
Correlation between KRAS, NRAS and BRAF mutations and tumor localizations in patients with primary and metastatic colorectal cancer
Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study - The Lancet Oncology
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
EGFR and bevacizumab in first-line KRAS wild-type tumours: randomized... | Download Scientific Diagram
Life | Free Full-Text | Integrated Decision-Making in the Treatment of Colon -Rectal Cancer: The Case of KRAS-Mutated Tumors
Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma
IJMS | Free Full-Text | The Role of KRAS Mutation in Colorectal Cancer-Associated Thrombosis
